FCGR2A and neoplasm: Western blot (WB) analysis further confirmed this upregulation, with tumor tissues displaying a 5-fold increase in FCGR2A levels compared to adjacent liver (6.24 ± 4.28% vs. 1.20 ± 0.97%).